デフォルト表紙
市場調査レポート
商品コード
1327572

淋菌検査の世界市場 - 市場規模(金額・数量・ASP):セグメント別、シェア、動向、SWOT分析、規制と償還の情勢、処置、予測(~2033年)

Neisseria Gonorrhoeae Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033

出版日: | 発行: GlobalData | ページ情報: 英文 | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.09円
淋菌検査の世界市場 - 市場規模(金額・数量・ASP):セグメント別、シェア、動向、SWOT分析、規制と償還の情勢、処置、予測(~2033年)
出版日: 2023年06月30日
発行: GlobalData
ページ情報: 英文
納期: 即納可能 即納可能とは
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の淋菌検査市場について調査分析し、各セグメントの市場規模、市場動向、競合情勢、COVID-19の影響などの情報を提供しています。

市場モデルの主な内容は以下の通りです。

上市済みの淋菌検査と進化する競合情勢

  • 主な業界動向の考察
  • 淋菌検査市場のセグメント別の年間収益と市場の見通し(2015年~2033年)
  • ユニット、平均販売価格、市場金額に関する市場レベルのデータ

世界、地域、国レベルの市場固有の考察

  • 世界の動向を地域別に分類した定性的な市場固有の情報と国別の考察
  • 淋菌検査市場のSWOT分析
  • 淋菌検査市場の競合力学の考察と動向

医療制度の概要を含む真の全体像を把握することで、市場の理解を促進します。また、市場参入セグメントでは、償還政策や規制情勢についての情報を提供し、市場力学をより深く掘り下げることができます。

  • 国別の医療制度の概要
  • 国別の償還政策
  • 国別の医療技術に関する規制情勢

対象企業

  • Abbott Laboratories
  • Becton Dickinson and Co
  • ZeptoMetrix Corporation
  • Danaher Corp
  • F. Hoffmann-La Roche Ltd
  • Hologic Inc
  • Thermo Fisher Scientific Inc
  • その他
目次
Product Code: GDME641MM

Abstract

Neisseria Gonorrhoeae Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033 is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area.

The model discusses in detail the impact of COVID-19 on Neisseria Gonorrhoea Tests market for the year 2020 and beyond. Neisseria Gonorrhoea is one of the most common sexually transmitted disease (STD) worldwide, caused by the bacteria Neisseria gonorrhoea. N. gonorrhoea infections are more common in young adults. Other groups at higher risk of contracting gonorrhoea include individuals with multiple sexual partners, individuals with another STD, men who have sex with men (MSM), and sex workers. Increases in the incidence of Neisseria gonorrhoea infections are likely due in part, to a greater number of individuals being screened as well as the advent of improved screening techniques like Neisseria Gonorrhoea Nucleic Acid Amplification (NAAT) Tests, which are highly sensitive and specific.

Neisseria Gonorrhoea Tests includes Neisseria Gonorrhoea Nucleic Acid Amplification Tests (NAATs), Neisseria Gonorrhoea multiparameter CT/NG NAATs and other Neisseria Gonorrhoea tests (Direct Fluorescent Antibody (DFA), Indirect Fluorescent Antibody (IFA), Immunochromatography, Cell Culture and Point of Care devices) as sub-segments.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are:

Currently marketed Neisseria Gonorrhoeae Tests and evolving competitive landscape:

  • Insightful review of the key industry trends.
  • Annualized total Neisseria Gonorrhoeae Tests market revenue by segment and market outlooks from 2015- 2033.
  • Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights:

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for Neisseria Gonorrhoeae Tests market.
  • Competitive dynamics insights and trends provided for Neisseria Gonorrhoeae Tests market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Abbott Laboratories, Becton Dickinson and Co, ZeptoMetrix Corporation, Danaher Corp, F. Hoffmann-La Roche Ltd, Hologic Inc, Thermo Fisher Scientific Inc, and others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina. and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for:

  • CMO executives who must have deep understanding of the Neisseria Gonorrhoeae Tests market place to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to:

  • Understand the impact of COVID-19 on Neisseria Gonorrhoeae Tests market.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving Neisseria Gonorrhoeae Tests market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Neisseria Gonorrhoeae Tests market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Neisseria Gonorrhoeae Tests market from 2015-2033.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.